Pharmaco - Press Releases

Date	Title	Company
19-Nov-2020	EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY	Evotec SE
19-Nov-2020	Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its Third Quarter 2020 Business Update on November 26, 2020	Vivoryon Therapeutics AG
19-Nov-2020	INEX Innovate's iGene Laboratory announces new personalised medicine genotyping analysis project with Eli Lilly and Company's research unit Lilly Centre for Clinical Pharmacology	INEX Innovate
18-Nov-2020	Flu Vaccinations For Seniors Are More Important Than Ever	Conviva Care Centers
18-Nov-2020	LILLY’S EMGALITY® ▼(GALCANEZUMAB) RECEIVES A POSITIVE RECOMMENDATION FROM NICE FOR THE PREVENTION OF EPISODIC AND CHRONIC MIGRAINE	Eli Lilly and Company
18-Nov-2020	Taiwan Surgical Corporation Launched InnoClipTM 5mm Multi-fire Titanium Clip Applier to Facilitate the Outcome of Minimally Invasive Surgery (MIS)	Taiwan Surgical Corporation (TWSC)
18-Nov-2020	Asahi Kasei Pharma Contracts ProBioGen for the Advancement of their Biologics Pipeline	Asahi Kasei Pharma
18-Nov-2020	ReveraGen Receives $3.3 Million NIH Commercialization Readiness Pilot Grant for NDA Preparations for Vamorolone in Duchenne Muscular Dystrophy	ReveraGen
18-Nov-2020	Vivet Therapeutics and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for Wilson Disease	Vivet Therapeutics and Pfizer Inc.
18-Nov-2020	FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease	Sanofi
18-Nov-2020	Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia	Sanofi
18-Nov-2020	Emergex Vaccines Raises US$11 million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases	Emergex
18-Nov-2020	Ardigen and BioCollective partner to detect early signs of Parkinson’s Disease for better diagnosis and treatment	Sciad Newswire
18-Nov-2020	Asahi Kasei Pharma Contracts ProBioGen for the Advancement of their Biologics Pipeline	B3C newswire
18-Nov-2020	QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours	QBiotics Group Limited
18-Nov-2020	QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours	QBiotics Group Limited
18-Nov-2020	Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes	Bausch Health Companies Inc.
18-Nov-2020	Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer	Elevation Oncology
18-Nov-2020	Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility	Samsung Biologics
18-Nov-2020	Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT	Milestone Pharmaceuticals, Inc.